LivingGLP1
Study S002180

A Pilot Single-Arm Open-Label Study to Evaluate the Efficacy of Treatment With Lixisenatide in Diabetes Mellitus Type 2 Patients With Failure of Other GLP-1 Analog

Registration

Registration
NCT02767596
Study type
INTERVENTIONAL
Phase
PHASE4
Masking
NONE
Status
TERMINATED
Enrollment
2
Start
2016-07-12
Primary completion
2017-02
Lead sponsor
Laniado Hospital
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG:Lixisenatide; DRUG:Basal insulins
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Change in hemoglobin A1c [16 weeks]
  • Change in body weight [16 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.